Tag: gilead sciences

June 22, 2020

7 Small Biotech ETFs

Want to invest in small biotech ETFs? INN profiles seven examples that life science investors may want to look into.
May 3, 2020

Coronavirus Round-Up: Possible Treatment Raises Hopes

As the new week kicks off, here’s a round-up of the Investing News Network’s top stories last week covering the...
April 29, 2020

Gilead Shares Phase 3 Trial Results for Remdesivir in COVID-19 Patients

Gilead Sciences announced the results of a Phase 3 trial of investigational antiviral remdesivir in patients with severe COVID-19. 
April 24, 2020

5 Top Biotechnology ETFs

For investors looking for less volatility compared to stocks, here's an overview of the five largest biotechnology ETFs for consideration.
February 27, 2020

Barclays Sees Upside in US Biopharma Industry

Barclays Capital has initiated coverage of the US biopharma space and will follow 16 companies in the market.
January 30, 2020

How to Invest in Biotechnology

What options exist for investors who want to invest in biotechnology? From stocks to ETFs, there are plenty of choices.
January 6, 2020

HOOKIPA Advances HIV and HBV Vaccine Research with Gilead

HOOKIPA Pharma announced that it has made progress in its research with Gilead Sciences for therapeutics for chronic HBV and...